Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation
- PMID: 20184930
- DOI: 10.1016/j.jconrel.2010.02.018
Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation
Abstract
Spray-freeze drying (SFD) is an attractive technique to prepare highly porous dry powders for inhalation. However, there have been few reports of its application to dry powder inhalers (DPIs). Therefore, in this study, we prepared dry plasmid DNA (pDNA) powders with different molecular ratios of chitosan to pDNA (N/P ratios) by SFD. All the pDNA powders were spherical and highly porous, with particles approximately 20-40microm in geometric diameter. The morphology changed little with the alteration of the N/P ratio. On electrophoresis, a band of linear pDNA was detected in the preparation without chitosan, suggesting the destabilization of pDNA through SFD. However, the addition of chitosan protected pDNA from destabilization. Moreover, the pDNA powders were evaluated for pulmonary gene transfection efficiency using an in vivo dual imaging technique for gene DPIs developed previously. Maximum gene expression was observed at 9-12h following pulmonary administration of the powders into mice. The powder with the N/P ratio of 10 had the highest gene transfection efficiency. A higher affinity of chitosan for pDNA and a smaller (approximately 100nm) pDNA/chitosan complex (N/Pf10) were found at pH 6.5 (in lung) than at pH 7.4 (in physiological conditions), suggesting that the effective compaction of pDNA by chitosan at the N/P ratio of 10 at pH 6.5 contributes to the gene transfection efficiency in the lung. These results suggest inhalable dry pDNA powders with chitosan prepared by SFD to be a suitable formulation for pulmonary gene therapy.
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence.J Control Release. 2009 Mar 4;134(2):149-54. doi: 10.1016/j.jconrel.2008.11.018. Epub 2008 Nov 30. J Control Release. 2009. PMID: 19100298
-
Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process.Int J Pharm. 2005 Feb 16;290(1-2):73-81. doi: 10.1016/j.ijpharm.2004.11.026. Epub 2005 Jan 11. Int J Pharm. 2005. PMID: 15664132
-
The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.J Gene Med. 2005 Aug;7(8):1035-43. doi: 10.1002/jgm.749. J Gene Med. 2005. PMID: 15756712
-
[Local and systemic delivery of high-molecular weight drugs by powder inhalation].Yakugaku Zasshi. 2007 Apr;127(4):643-53. doi: 10.1248/yakushi.127.643. Yakugaku Zasshi. 2007. PMID: 17409693 Review. Japanese.
-
Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation.Curr Pharm Des. 2015;21(27):3854-66. doi: 10.2174/1381612821666150820105916. Curr Pharm Des. 2015. PMID: 26290202 Review.
Cited by
-
Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying.Pharmaceutics. 2015 Aug 26;7(3):233-54. doi: 10.3390/pharmaceutics7030233. Pharmaceutics. 2015. PMID: 26343708 Free PMC article.
-
Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.Pharm Res. 2016 Apr;33(4):922-31. doi: 10.1007/s11095-015-1838-4. Epub 2015 Dec 7. Pharm Res. 2016. PMID: 26643921
-
Approaches and applications in transdermal and transpulmonary gene drug delivery.Front Bioeng Biotechnol. 2025 Jan 15;12:1519557. doi: 10.3389/fbioe.2024.1519557. eCollection 2024. Front Bioeng Biotechnol. 2025. PMID: 39881959 Free PMC article. Review.
-
Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice.Mol Ther Nucleic Acids. 2018 Sep 7;12:698-706. doi: 10.1016/j.omtn.2018.07.009. Epub 2018 Jul 17. Mol Ther Nucleic Acids. 2018. PMID: 30092405 Free PMC article.
-
Delivery of pDNA Polyplexes to Bronchial and Alveolar Epithelial Cells Using a Mesh Nebulizer.Pharm Res. 2018 Nov 15;36(1):14. doi: 10.1007/s11095-018-2542-y. Pharm Res. 2018. PMID: 30443858
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous